Finance

Lists
ORCHPHARMA:NSE
Orchid Pharma Ltd
₹958.15
+1.01%
(+9.55) 1D
Nov 20, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ORCHPHARMA...
Open
₹948.60
High
₹970.15
Low
₹943.85
Mkt. cap
57.38B
Avg. vol.
107.01K
Volume
66.76K
P/E ratio
190.76
52-wk high
₹1,143.50
52-wk low
₹480.00
EPS
₹5.02
No. of employees
1K
Open
₹948.60
High
₹970.15
Low
₹943.85
Mkt. cap
57.38B
Avg. vol.
107.01K
Volume
66.76K
P/E ratio
190.76
52-wk high
₹1,143.50
52-wk low
₹480.00
EPS
₹5.02
No. of employees
1K
News stories
From web sources and news partners
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees1.17K
Founded1992
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 17, 2026
Fiscal period
Q2 2027
₹4.77 / ₹2.50
+90.80%beat
Revenue / Est. (INR)
3.41B / 3.65B
-6.50%miss
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.07B
6.59B
3.04B
3.41B
Cost of goods sold
1.43B
5.03B
2.04B
2.08B
Cost of revenue
1.43B
5.03B
2.04B
2.08B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
241.28M
502.27M
280.38M
314.05M
Operating expense
715.86M
1.40B
968.16M
1.20B
Total operating expenses
2.15B
6.43B
3.01B
3.29B
Operating income
-74.65M
163.81M
30.51M
127.24M
Other non operating income
56.09M
-238.03M
18.28M
177.56M
EBT including unusual items
-121.46M
115.38M
32.97M
285.49M
EBT excluding unusual items
-50.34M
38.30M
32.97M
285.49M
Income tax expense
-
17.00K
723.00K
-449.00K
Effective tax rate
-
0.01%
2.19%
-0.16%
Other operating expenses
384.29M
419.31M
578.29M
772.91M
Net income
-121.46M
115.36M
32.24M
285.94M
Net profit margin
-5.86%
1.75%
1.06%
8.38%
Earnings per share
-1.08
4.58
0.54
4.77
Interest and investment income
-
101.25M
-
-
Interest expense
-31.78M
-
-22.30M
-36.43M
Net interest expenses
-31.78M
101.25M
-22.30M
-36.43M
Depreciation and amortization charges
90.29M
166.61M
109.49M
114.12M
EBITDA
10.45M
269.63M
119.14M
239.05M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps